Cost estimates of prophylaxis.
Moler
F
F
D001835:Body Weight; D003362:Cost-Benefit Analysis; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics* / Q000627:therapeutic use; D007223:Infant; D018357:Respiratory Syncytial Virus Infections / Q000191:economics* / Q000517:prevention & control; D012136:Respiratory Syncytial Viruses / Q000276:immunology
D016756:Immunoglobulins, Intravenous